Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smartwatches and scales could aid ICU recovery, pilot study explores

NCT ID NCT07035106

Knowledge-focused Sponsor: Ludwig Boltzmann Gesellschaft Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This pilot study is testing whether wearable devices like smartwatches, blood pressure monitors, and smart scales can help patients recover after a stay in the intensive care unit (ICU). Many ICU survivors face physical and mental challenges, known as Post-Intensive Care Syndrome. The study will enroll 60 adults who had a heart condition or diabetes and were in the ICU for at least 48 hours. Participants will either receive standard care, use wearables alone, or use wearables plus bi-weekly health summaries and optional lifestyle coaching. The goal is to see if these tools are practical and helpful for recovery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Wearable health devices (Garmin Vivosmart 5, smart scale, blood pressure monitor) and digital health summaries with optional lifestyle counseling
What this could lead to
If successful, this could show that wearable technology and digital summaries are practical tools to support recovery after intensive care.
What could go wrong
This is a small pilot study with only 60 participants, so results may not apply to everyone. The technology might be difficult for some patients to use consistently.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2025

Expected to finish

May 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18-65 years at the time of ICU admission * ICU stay of at least 48 hours * ICU discharge within the last 2 years * Comorbidity of diabetes mellitus and/or chronic heart failure/coronary artery disease * Written informed consent * Access to a home internet connection and smartphone with internet and Bluetooth Exclusion Criteria: * Presence of a legal guardian * No smartphone or internet access * No cardiovascular disease/event and/or diabetes * Implanted pacemaker or defibrillator * Allergies to materials in the wearable devices * Transfer from an ICU outside the Medical University of Vienna * Homelessness * Residence outside of Austria

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic heart failure are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cardiovascular disorder congestive heart failure coronary artery disorder diabetes mellitus postintensive care syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Coronary artery disease Critical illness recovery Post-intensive care syndrome (PICS)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Ludwig Boltzmann Institute Digital Health and Patient Safety

    RECRUITING

    Vienna, 1090, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.